Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6686 record(s)

Req # A-2024-000748

Adverse Drug Reactions (ADRs). Report numbers: E2B_06791238, E2B_07177078, 001026185, E2B_05649794, E2B_05046178.

Organization: Health Canada

217 page(s)
February 2025

Req # A-2024-000785

Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_07292216, E2B_07257754, E2B_07256411. ADRs for Pantoprazole sodium. Report numbers: E2B_07289678, E2B_07302776, E2B_07300609, E2B_07265897, E2B_07283554, 001099662. ADR for…

Organization: Health Canada

2085 page(s)
February 2025

Req # A-2024-000826

Adverse Drug Reactions (ADRs). Report numbers: 001097163, E2B_07314826, 001095679.

Organization: Health Canada

194 page(s)
February 2025

Req # A-2024-000840

Adverse Drug Reactions (ADRs) for . Report numbers: E2B_07270600, E2B_07256900.

Organization: Health Canada

54 page(s)
February 2025

Req # A-2024-000844

Adverse Drug Reactions (ADRs). Report numbers: E2B_06576446, E2B_07291807, E2B_07242295, E2B_07242732.

Organization: Health Canada

67 page(s)
February 2025

Req # A-2024-000905

Adverse Drug Reactions (ADRs). Report numbers: E2B_06729415, 001059606, E2B_06640045, E2B_06695186, E2B_06724909, 001060637.

Organization: Health Canada

2157 page(s)
February 2025

Req # A-2024-000918

Adverse Drug Reactions (ADRs). Report numbers: E2B_07311444, E2B_06616049, E2B_07304055, 001092607, E2B_04857532, E2B_07285839, E2B 03541647, 001091444, 000947892, E2B_07309170.

Organization: Health Canada

1484 page(s)
February 2025

Req # A-2024-000935

Adverse Drug Reactions (ADRs). Report numbers: E2B_00465828, 001102591, 001097155.

Organization: Health Canada

331 page(s)
February 2025

Req # A-2024-001010

Adverse Drug Reactions (ADRs). Report numbers: E2B_07142259, E2B_07238200, E2B_07214768, 001088932, E2B_07214773.

Organization: Health Canada

49 page(s)
February 2025

Req # A-2024-001033

Adverse Drug Reactions (ADRs). Report numbers: E2B_07106036, E2B_07274964, 001106563, 001109888, E2B_07203089, E2B_02534436, 001098065, 001100175, E2B_07210682, 001100176.

Organization: Health Canada

340 page(s)
February 2025
Date modified: